XEOU:SW:SW-Xtrackers MSCI Europe UCITS ETF 2C - USD Hedged (USD)

ETF | Others |

Last Closing

USD 17.19

Change

+0.16 (+0.96)%

Market Cap

USD 0.27B

Volume

8.64K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.11 (+0.86%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.29 (+1.42%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.10 (+0.36%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.41 (+1.52%)

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-2.00 (-0.04%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+2.00 (+0.12%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+31.50 (+1.39%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.81 (+1.09%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

+1.02 (+0.91%)

USD 130,595.12B

ETFs Containing XEOU:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.08% 80% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.08% 80% B- 77% C+
Trailing 12 Months  
Capital Gain 11.36% 50% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.36% 49% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.60% 67% D+ 68% D+
Dividend Return 7.60% 67% D+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.97% 54% F 59% D-
Risk Adjusted Return 95.35% 86% B+ 87% B+
Market Capitalization 0.27B 45% F 41% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.